{
  "resourceType": "PlanDefinition",
  "id": "azathioprine-lower-dosage",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Azathioprine Myelotoxicity Intervention - Lower Dosage</div>"
  },
  "contained": [
    {
      "resourceType": "ActivityDefinition",
      "id": "intermediate-tpmt-metabolizer-detected-alert",
      "status": "active",
      "category": "communication",
      "dynamicValue": [
        {
          "path": "sender",
          "expression": "CDS System"
        },
        {
          "path": "recipient",
          "expression": "Primary Provider"
        },
        {
          "path": "payload.content",
          "expression": "'Testing has been performed and indicates that this patient is at INCREASED risk for myelotoxicity with standard dosing of thiopurine therapy.'"
        },
        {
          "path": "payload.content",
          "expression": "'Based on a test result, this patient is predicted to be an intermediate TPMT metabolizer.           The patient is at risk for myelosuppression with normal doses of azathioprine. A normal starting dose           of azathioprine (e.g. 2-3 mg/kg/day) should be reduced to 0.6 â€“ 2 mg/kg/day. Please consult a           {{recommended clinical professional for consultation, for example some institutions might direct to a clinical pharmacist}}.'"
        },
        {
          "path": "status",
          "expression": "'proposed'"
        },
        {
          "path": "encounter",
          "expression": "Encounter"
        },
        {
          "path": "scheduled",
          "expression": "Now()"
        },
        {
          "path": "reason",
          "expression": "Intermediate TPMT Metabolizer Detected"
        },
        {
          "path": "requestedOn",
          "expression": "Now()"
        },
        {
          "path": "subject",
          "expression": "Patient"
        },
        {
          "path": "priority",
          "expression": "Code 'urgent' from DiagnosticPriority display 'Urgent'"
        }
      ]
    }
  ],
  "identifier": [
    {
      "use": "official",
      "value": "azathioprine-myelotoxicity-lower-dosage"
    }
  ],
  "version": "1.0.0",
  "title": "Azathioprine Myelotoxicity Lower Dosage",
  "status": "active",
  "description": "Azathioprine myelotoxicity intervention to alert the user that the dosage of Azathioprine should be lowered due to the patient's intermediate metabolizer status.",
  "publicationDate": "2016-04-01",
  "topic": [
    {
      "text": "Azathioprine Myelotoxicity - Lower Dosage"
    }
  ],
  "library": [
    {
      "reference": "Library/library-azathioprine-myelotoxicity-cds-logic"
    }
  ],
  "actionDefinition": [
    {
      "title": "Patient Shows Intermediate Metabolic Status in TPMT Genotype Test Results.",
      "textEquivalent": "The Patient has intermediate metabolic status in their TPMT Genotype Test results.",
      "triggerDefinition": [
        {
          "type": "data-added",
          "eventData": {
            "type": "MedicationOrder",
            "codeFilter": [
              {
                "path": "code",
                "valueCodeableConcept": [
                  {
                    "coding": [
                      {
                        "system": "http://snomed.org/sct",
                        "code": "372574004"
                      }
                    ],
                    "text": "Azathioprine (substance)"
                  }
                ]
              }
            ]
          }
        }
      ],
      "condition": {
        "language": "text/cql",
        "expression": "Should Notify User to Lower Dosage"
      },
      "participantType": [
        "practitioner"
      ],
      "type": {
        "code": "create"
      },
      "dynamicValue": [
        {
          "path": "/",
          "expression": "intermediate-tpmt-metabolizer-detected-alert"
        }
      ]
    }
  ]
}